ReviewArchives of medical science : AMS2025
Prevalence and incidence of chest wall deformities in children below 18 years old: the first systematic review and meta-analysis.
Review in Archives of medical science : AMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Congenital Chest Wall Deformities in Children: A Narrative Review.Children (Basel, Switzerland) · 2026Review
- Performance of ChatGPT-4o, Gemini 2.0 Pro, and DeepSeek-V3 in Patient-Facing Information on Chest Wall Deformities: A Comparative Evaluation of Accuracy, RELIABILITY, and Reproducibility.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The chest wall can exhibit a wide range of abnormalities, from pectus carinatum (PC), which is a protrusion defect, to pectus excavatum (PE), a depression defect. This meta-analysis aimed to evaluate the prevalence and incidence of chest wall deformities (CWDs) in children aged below 18. Material and methods: The databases of Cochrane Library, PubMed, Scopus, and Web of Science were searched until March 23, 2024, with an age limitation. The CMA version 3.0 software was used to calculate the effect sizes, presenting the event rate (ER). A subgroup analysis was conducted based on continents. Results: Out of 1,510 initial records, 34 articles were entered into the analysis. The pooled ER of PE, PC, pectus deformities (PDs), and rib anomaly is 0.5%, 0.6%, 1.2%, and 0.05%, respectively. The pooled ER is 11.4% for the Marfan's syndrome incidence in PDs, 19.7% for the mitral valve prolapse incidence in PDs, 6.2% for the incidence of CWD in cancers, 2.6% for the incidence of PDs in congenital heart disease, 16% for the incidence of scoliosis in PE, 11.1% for the incidence of cardiac anomalies in PDs, 13.4% for the incidence of abnormal electrocardiogram in PDs, 12.6% for the incidence of aortic root dilation in PDs, 6.3% for the tricuspid valve prolapse incidence in PDs, and 2% for the congenital heart disease incidence in PE. Conclusions: The higher incidence of certain conditions in individuals with PDs underscores the importance of regular monitoring and comprehensive care for these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.